Join Now

The voice of utah’s life sciences community

BioUtah is the common voice and flag bearer for Utah’s life sciences industry comprised of medical devices, pharmaceutical, diagnostics, and biotechnology. Together we form an ecosystem that fosters collaboration, promotes innovation and delivers technology that saves lives.

Learn More

Medical Device

Pharmaceuticals

Diagnostics / Laboratory

Biotechnology

Icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY

Utah Life Sciences by the Numbers

Kem C. Gardner Report Findings Nov. 2023

Utah is #3 in the nation for life sciences growth.

Life sciences is a $21.6 billion industry in Utah.

Source: Pace, L. and Brandley, A. (2023), Economic Impacts of Utah’s Life Sciences and Health Care Innovation Industry: Utah’s Life Sciences and Health Care Innovation Industry Creates Substantial Economic Impacts Across the State, Kem C. Gardner Policy Institute, University of Utah.

BioUtah News

June 19, 2025
Policy News
2025 BIO International Recap

BioUtah and its Utah consortium made their mark this week at the BIO International Conference, hosting a Utah Pavillion to promote the state’s fast-growing life sciences industry. The conference, held in Boston, MA. drew appproximately 20,000 attendees. The Utah delegation included BioUtah, Utah life sciences companies, the Governor’s Office of Economic Development, the Unversity of […]

June 19, 2025
BioUtah News
Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a Novel LRRK2 Inhibitor Targeting Neuroinflammation

Completion of SAD/MAD trial marks advancement toward further clinical development of HT-4253 in Alzheimer’s and other neurodegenerative diseases.

June 19, 2025
BioUtah News
Nelson Labs to Double Cleanroom Capacity to Support Growing Demand for Sterility Assurance Services

Strategic Expansion in Salt Lake City Headquarters Will Meet Stringent EU GMP Annex 1 Requirements

June 19, 2025
BioUtah News
RATIO THERAPEUTICS AND NUSANO ENTER LONG-TERM, MULTI-ISOTOPE SUPPLY AGREEMENT TO BOOST PRODUCTION OF CANCER RADIOPHARMACEUTICALS

AGREEMENT PROVIDES RATIO ACCESS TO NUSANO-PRODUCED RADIOISOTOPES FOR ONCOLOGY DIAGNOSTICS AND THERAPEUTICS

June 19, 2025
BioUtah News
Microvascular Therapeutics announces Founder and CEO Dr. Evan Unger as panelist in Commercializing SBIR/STTR Technologies Discussion at BIO 2025

Microvascular Therapeutics announces Founder and CEO Dr. Evan Unger as panelist in Commercializing SBIR/STTR Technologies Discussion at BIO 2025

June 12, 2025
BioUtah News
June 12, 2025
BioUtah News
Rebel Medicine Announces Series A Financing and Investigational New Drug (IND) Application Opening to Advance Non‑Opioid Pain Therapeutic into Clinical Development

Rebel Medicine Announces Series A Financing and Investigational New Drug (IND) Application Opening to Advance Non‑Opioid Pain Therapeutic into Clinical Development

June 12, 2025
BioUtah News
NUSANO STABLE ISOTOPE PROGRAM ENRICHES GADOLINIUM-160 TO 99.2% PURITY

DOMESTIC STABLE ISOTOPE PROGRAM KEY TO STABILIZING SUPPLY CHAINS, ENABLING INNOVATION

From Here to There

See how BioUtah, the only trade association dedicated solely to Utah’s Life Sciences industry, can help your business grow.


Networking

Advocacy

Investment

Workforce Development

2024 Utah Life Sciences Award Recipients

Lifetime Achievement
Dr. Wm. Dean Wallace

Innovation Impact
Blackrock Neurotech

Entrepreneur of the Year
Jay Muse

Executive of the Year
Bradford Brown

Friend of Industry
Vic Hockett

BioUtah is Powered by

Legacy Sponsors

Platinum Sponsors

Gold Sponsors

Silver Sponsors

Bronze Sponsors